GSTA2 and hepatocellular carcinoma: Overexpression of GSTA2 in HCC cells suppressed its ROS-mediated activation of the JNK pathway, while suppression of GSTA2 enhanced the activation of the JNK pathway of HCC cells under an increased ROS condition (Fig. 3d).